ACE2 and Miyoshi myopathy: Of note, cross-neutralisation to VOCs (i.e., inhibition of Omicron BA.4/5 and XBB.1.5 RBD binding to ACE-2) was strongly increased after BTI in MM patients and controls (Figure 6D,E); full symbols.